Use of STAT3 polymorphisms to predict overall survival in patients treated with interferon-alpha for metastatic renal cell carcinoma.
Masatoshi Eto
No relevant relationships to disclose
Tomomi Kamba
No relevant relationships to disclose
Hideaki Miyake
No relevant relationships to disclose
Masato Fujisawa
No relevant relationships to disclose
Takao Kamai
No relevant relationships to disclose
Hirotsugu Uemura
No relevant relationships to disclose
Taiji Tsukamoto
No relevant relationships to disclose
Haruhito Azuma
No relevant relationships to disclose
Akio Matsubara
No relevant relationships to disclose
Kazuo Nishimura
No relevant relationships to disclose
Tsuyoshi Nakamura
No relevant relationships to disclose
Osamu Ogawa
No relevant relationships to disclose
Seiji Naito
No relevant relationships to disclose